Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
DOI
PMC
 |
|
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature.
Leuk. Lymphoma 54, 1652-1657 (2013)
We recently identified the marginal zone B and B1 cellspecific protein ( MZB1 ) as part of a gene expression signature associated with outcomes in chronic lymphocytic leukemia (CLL). MZB1 is important for B cell function as a key regulator of antibody secretion, calcium homeostasis and adhesion. Therefore, we analyzed the role of MZB1 expression levels in 139 patients with CLL using quantitative real-time polymerase chain reaction (qRT-PCR) and microarray data sets in CLL, follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), multiple myeloma (MM) and acute myeloid leukemia (AML). High MZB1 expression was associated with inferior survival in CLL (hazard ratio [HR]: 1.63 [confidence interval (CI): 1.14 – 2.33], p 0.007), FL (221286_s_at HR: 1.16 [CI: 0.98 – 1.37], p 0.086; 223565_at: HR: 1.3 [CI: 1.1 – 1.61], p 0.015) and DLBCL (221286_s_at: HR: 1.17 [CI: 1.06 – 1.3], p 0.003; 223565_at: HR: 1.21 [CI: 1.08 – 1.35], p 0.001). In DLBCL MZB1 expression was an additive prognostic marker in a multivariate model including activated B-cell like (ABC) versus germinal center (GCB) subtype. Additionally, MZB1 expression correlated with a unique gene expression pattern. This study is the first to show that the expression level of a single gene has prognostic significance in different lymphoma subtypes. Due to its biological function, MZB1 may play a central role in B cell neoplasms and is a potential target for future therapeutic interventions.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
MZB1; gene expression; survival; lymphoma; Protein Disulfide-isomerase ; Survival ; Differentiation ; Cancer ; Activation ; Secretion ; Nfatc1 ; Perp1
ISSN (print) / ISBN
1042-8194
e-ISSN
1029-2403
Zeitschrift
Leukemia and Lymphoma
Quellenangaben
Band: 54,
Heft: 8,
Seiten: 1652-1657
Verlag
Informa Healthcare
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed